Lanean...
Hospitalization and Survival of Medicare Patients Treated With Carboplatin Plus Paclitaxel or Pemetrexed for Metastatic, Nonsquamous, Non–Small Cell Lung Cancer
IMPORTANCE: Chemotherapy is a mainstay treatment of metastatic non–small cell lung cancer. However, little is known about the comparative risk of hospitalization associated with commonly used chemotherapy regimens. OBJECTIVE: To evaluate the real-world association of specific lung cancer chemotherap...
Gorde:
| Argitaratua izan da: | JAMA Netw Open |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
American Medical Association
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6324452/ https://ncbi.nlm.nih.gov/pubmed/30646220 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2018.3023 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|